Cobalt alloy for medical implants and stent comprising the alloy

US9757224B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9757224-B2
Application numberUS-201313910326-A
CountryUS
Kind codeB2
Filing dateJun 5, 2013
Priority dateJun 18, 2012
Publication dateSep 12, 2017
Grant dateSep 12, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An embodiment of the invention relates to a cobalt-based alloy, which due to the composition exhibits twinning as the dominating deformation mechanism: Cr: 13.0 to 30.0% by weight Mn: 2.0 to 10.0% by weight W: 2.0 to 18.0% by weight Fe: 5.0 to 15.0% by weight C: 0.002 to 0.5% by weight N: 0 to 0.2% by weight Si: 0 to 2.0% by weight Ni: 0 to 5.0% by weight wherein the aforementioned alloying components and manufacturing-related impurities add up to 100% by weight, and the following restrictions according to formulas (1) and (2) apply to the contents of nitrogen and carbon, and the following restrictions according to formula (3) apply to the contents of oxygen, phosphorus and sulfur: 0.003%≦C+N≦0.5% weight  (1) N/C(wt. %)≦1.00 for 0.07%<C<0.15% (weight)  (2) O+P+S<0.10% weight  (3).

First claim

Opening claim text (preview).

What is claimed is: 1. A cobalt alloy comprising a tensile strength of greater than 900 MPa and having the following composition: Cr: 13.0 to 30.0% by weight Mn: 2.0 to 10.0% by weight W: 2.0 to 18.0% by weight Fe: 5.0 to 15.0% by weight C: 0.002 to 0.5% by weight N: 0 to 0.2% by weight Si: 0 to 2.0% by weight Ni: 2.0 to 3.5% by weight Co: balance, wherein the aforementioned alloying components and manufacturing-related impurities add up to 100% by weight, and the following restrictions according to formulas (1) and (2) apply to the contents of nitrogen and carbon, and the following restrictions according to formula (3) apply to the contents of oxygen, phosphorus and sulfur: 0.003%≦C+N≦0.5% (by weight)  (1) N/C(wt. %)≦1.00 for 0.07%<C<0.15% (by weight)  (2) O+P+S<0.10% (by weight)  (3), wherein the alloy is free from Mo. 2. The alloy according to claim 1 , wherein a content of Cr in the alloy is 17.0 to 25.0% by weight. 3. The alloy according to claim 1 , wherein a content of Mn in the alloy is 4.0 to 10.0% by weight. 4. The alloy according to claim 1 , wherein a content of W in the alloy is 9.0 to 18.0% by weight. 5. The alloy according to claim 1 , wherein a content of Fe in the alloy is 9.5 to 10.5% by weight. 6. The alloy according to claim 1 , wherein a content of Si in the alloy is less than 0.7% by weight. 7. The alloy according to claim 1 , wherein a content of C in the alloy is 0.002 to 0.15% by weight. 8. The alloy according to claim 1 , wherein a content of C in the alloy is 0.07 to 0.15% by weight and N/C (wt. %) ranges between 0.25 and 1. 9. The alloy according to claim 1 , wherein a content of Ni in the alloy is 2.5 to 3.5% by weight. 10. The alloy according to claim 1 , wherein a content of Ni in the alloy is 2.5 to 3.5% by weight, and the total weight % of C and N together is between 0.003 and 0.3. 11. The alloy according to claim 1 , wherein the total weight % of C and N together is between 0.003 and 0.1. 12. The alloy according to claim 1 wherein Cr is present in a weight % of between 19.0 and 21.0. 13. The alloy according to claim 1 wherein W is present in a weight % of between 14.5% to 15.5%. 14. The alloy according to claim 1 wherein the Si is present in a weight % between 0.05 to 0.5%. 15. The alloy according to claim 1 wherein the alloy is free of Ti, Ta, Nb and Al. 16. The alloy according to claim 1 wherein the content of O, S and P in alloy is below 0.07% weight in total. 17. A cobalt alloy, having the following composition: Cr: 13.0 to 30.0% by weight Mn: 2.0 to 10.0% by weight W: 2.0 to 18.0% by weight Fe: 5.0 to 15.0% by weight C: 0.002 to 0.5% by weight N: 0 to 0.2% by weight Si: 0 to 2.0% by weight Ni: 2.0 to 3.5% by weight Co: balance, wherein the aforementioned alloying components and manufacturing-related impurities add up to 100% by weight, and the following restrictions according to formulas (1) and (2) apply to the contents of nitrogen and carbon, and the following restrictions according to formula (3) apply to the contents of oxygen, phosphorus and sulfur: 0.003%≦C+N≦0.5% (by weight)  (1) N/C(wt. %)≦1.00 for 0.07%<C<0.15% (by weight)  (2) O+P+S<0.10% (by weight)  (3), wherein the alloy is free from Mo; and wherein the alloy has a stacking fault energy between 20 and 30 mJ/m 2 . 18. A stent comprising a filigree support structure made entirely or partially of a cobalt alloy comprising a tensile strength of greater than 900 MPa and having the following composition: Cr: 13.0 to 30.0% by weight Mn: 2.0 to 10.0% by weight W: 2.0 to 18.0% by weight Fe: 5.0 to 15.0% by weight C: 0.002 to 0.5% by weight N: 0 to 0.2% by weight Si: 0 to 2.0% by weight Ni: 0 to 3.5% by weight Co: balance, wherein the aforementioned alloying components and manufacturing-related impurities add up to 100% by weight, and the following restrictions according to formulas (1) and (2) apply to the contents of nitrogen and carbon, and the following restrictions according to formula (3) apply to the contents of oxygen, phosphorus and sulfur: 0.003%≦C+N≦0.5% (wt.)  (1) N/C(wt. %)≦1.00 for 0.07%<C<0.15% (wt.)  (2) O+P+S<0.10% (wt.)  (3) wherein the alloy is free from Mo. 19. A stent as defined by claim 18 , wherein the stent further includes a generally tubular shaped base body that is made entirely of the alloy.

Assignees

Inventors

Classifications

  • Metals or alloys · CPC title

  • C22C19/07Primary

    based on cobalt · CPC title

  • of nickel or cobalt or alloys based thereon · CPC title

  • A61F2/06Primary

    Blood vessels · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9757224B2 cover?
An embodiment of the invention relates to a cobalt-based alloy, which due to the composition exhibits twinning as the dominating deformation mechanism: Cr: 13.0 to 30.0% by weight Mn: 2.0 to 10.0% by weight W: 2.0 to 18.0% by weight Fe: 5.0 to 15.0% by weight C: 0.002 to 0.5% by weight N: 0 to 0.2% by weight Si: 0 to 2.0% by weight Ni: 0 to 5.0% by weight wherein the af…
Who is the assignee on this patent?
Biotronik Ag
What technology area does this patent fall under?
Primary CPC classification C22C19/07. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).